Is it Possible to Predict Falls With Motor Imagery (FallMI)

June 15, 2023 updated by: Centre Hospitalier Departemental Vendee

Pilot Study to Predict Falls With Motor Imagery

At Departmental Hospital Centre, a primary and secondary screening program for osteoporosis was set up in 2014 in the medical services (excluding oncology), gynaecology, outpatient surgery and orthopaedics. Patients who consulted outpatients in the emergency room were not taken into account due to the 24-hour opening hours. The objective of this program was to identify all patients at risk of osteoporosis; i. e. not only patients with a recent or previous fracture history, but also patients with osteoporosis risk factors without a history of fracture to date. This is in order to propose a prevention strategy to referring physicians and thus reduce the risk of fractures. The handover of the Timed Up and Go designed and physically carried out was added in July 2017 to the management of patients as part of this screening.

During this screening, patients are asked to perform 2 realized Timed Up and Go (rTUG), followed by 2 imagined Timed Up and Go (iTUG).

The interest in preventing falls in osteoporotic patients leads investigators to propose this evaluation as part of this "osteoporosis" screening. The investigators will offer patients benefiting from osteoporosis screening as part of the process already in place at Departmental Hospital Centre to participate in the FallMi study. If agreement is reached, the patient's treating physician will be contacted to collect data on the occurrence of falls in these patients. After a request by mail, an email will be sent to the attending physicians of each patient at 6 months, then one year after the completion of the TUG. This email will ask physicians about the presence of a fall that has occurred since the TUGs were performed, as well as the severity of this possible fall.

Investigators objective is to evaluate rTUG and iTUG as predictive factors of a fall with moderate to fatal consequences.

Investigators hypothesize that a lower isochrony between rTUG and iTUG is predictive of a risk of falling.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Fall of the elderly is a major public health problem, especially in people with fragile bones. Various tools are available to identify high-risk subjects. Timed Up and Go (TUG) is a clinical test used as a predictive test of fall. However, its real usefulness remains uncertain. The degradation of TUG appears to be validated after the fall, but discussed as a prediction of a future fall.

On the other hand, human movement is separable into 2 phases, a programming phase (anticipation) and an execution phase. Movement programming can be reliably assessed through a simple test that evaluates the concordance between the duration of an imagined practice and a physical practice . Adapted to Timed Up and Go (= |realizedTUG -imaginedTUG|), the degradation of this Isochronic Index clinically marks a structural and functional degradation of cognitive abilities . In addition, the decrease in isochrony is correlated with the decrease in walking speed during the double task. This loss of isochrony could thus indicate a risk of falling due to poor anticipation of real motor skills.

At Departmental Hospital Centre, a primary and secondary screening program for osteoporosis was set up in 2014 in the medical services (excluding oncology), gynaecology, outpatient surgery and orthopaedics. Patients who consulted outpatients in the emergency room were not taken into account due to the 24-hour opening hours. The objective of this program was to identify all patients at risk of osteoporosis; i. e. not only patients with a recent or previous fracture history, but also patients with osteoporosis risk factors without a history of fracture to date. This is in order to propose a prevention strategy to referring physicians and thus reduce the risk of fractures. The handover of the Timed Up and Go designed and physically carried out was added in July 2017 to the management of patients as part of this screening.

During this screening, patients are asked to perform 2 realized Timed Up and Go (rTUG), followed by 2 imagined Timed Up and Go (iTUG).

The interest in preventing falls in osteoporotic patients leads us to propose this evaluation as part of this "osteoporosis" screening. This study wills offer patients benefiting from osteoporosis screening as part of the process already in place at CHD to participate in the FallMi study. If agreement is reached, the patient's treating physician will be contacted to collect data on the occurrence of falls in these patients. After a request by mail, an email will be sent to the attending physicians of each patient at 6 months, then one year after the completion of the TUG. This email will ask the doctors about the presence of a fall that has occurred since the TUGs were performed, as well as the severity of this possible fall.

Investigators objective is to evaluate rTUG and iTUG as predictive factors of a fall with moderate to fatal consequences.

Investigators hypothesize that a lower isochrony between rTUG and iTUG is predictive of a risk of falling.

Study Type

Interventional

Enrollment (Estimated)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • La Roche-sur-Yon, France
        • Recruiting
        • Centre Hospitalier departemental
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Patients who have been screened for osteoporosis at CHD (aged 50 to 85 years)
  • Proven presence of osteoporotic risk (positive response to screening tests),
  • No lower limb fractures making walking impossible,
  • Realization of iTUG and rTUG.
  • No objection to the collection and analysis of personal data collected,
  • Patient can be followed during the study period (12 months),
  • Patient followed by a treating physician and having given his or her consent for him or her to be contacted as part of the study.

Exclusion Criteria:

  • Insane patient
  • Deaf patient
  • Complete blind patient
  • Patient unable to express himself
  • Patient at the end of life
  • Patient already treated for osteoporosis or recent DXA less than 3 years old at the time of screening
  • Patient who has not been screened for osteoporosis at the CHD
  • Presence of equipment (e.g. infusion) making it impossible to walk or rendering the reliability of TUGs obsolete,

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Motor imagery evaluation
cohort study

Imagined Timed Up and Go (iTUG) is the imagined version of the actual Timed Up and Go (rTUG) described above). It is possible to calculate the absolute value of the difference between the time of execution of the TUG imagined and actually executed. This difference is called isochrony index. The alteration of this isochrony index is correlated with the decrease in walking speed during the double task. This test is performed during the osteoporosis screening consultation.

For patients who agree to participate in the FallMI study, the name and contact information of the attending physician will be collected during the same consultation.

Standardised email will be sent to the attending physicians to collect the presence of falls and its consequences. They will be classified as fatal, severe, moderate and inconsequential.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
existence of an isochronic deficit between the imagined Timed Up and Go and the Timed Up and Go correlated with presence of a fall
Time Frame: 6 month
- Isochronic index =| rTUG-iTUG | (Absolute value of the difference between the execution time of the rTUG and the iTUG)
6 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluate the factors that predict a fall
Time Frame: 12 month
- Isochronic index =| rTUG-iTUG | (Absolute value of the difference between the execution time of the rTUG and the iTUG)
12 month
Assess the factors that predict a first fall
Time Frame: 6 and 12 month
- Isochronic index =| rTUG-iTUG | (Absolute value of the difference between the execution time of the rTUG and the iTUG)
6 and 12 month
Assess whether factors are predictive of the severity of a fall
Time Frame: 6 and 12 month
- Isochronic index =| rTUG-iTUG | (Absolute value of the difference between the execution time of the rTUG and the iTUG)
6 and 12 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Thomas Rulleau, PT PhD, CHD-Vendée

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 4, 2019

Primary Completion (Estimated)

December 4, 2025

Study Completion (Estimated)

December 4, 2026

Study Registration Dates

First Submitted

July 22, 2019

First Submitted That Met QC Criteria

July 29, 2019

First Posted (Actual)

July 31, 2019

Study Record Updates

Last Update Posted (Estimated)

June 16, 2023

Last Update Submitted That Met QC Criteria

June 15, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • CHD 032-18

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fall Patients

Clinical Trials on Motor Imagery Test

3
Subscribe